XML 65 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1

Earnings (Loss) per Share (Tables)

12 Months Ended

Dec. 31, 2023

Schedule of Earnings per Share

The net income (loss) attributable to Teva and the weighted average number of ordinary shares used in the computation of basic and diluted earnings (loss) per share for the years ended December 31, 2023, 2022 and 2021 are as follows:

		Year ended December, 31
		2023				2022				2021
		(U.S. $ in millions, except share data)
Net income (loss) used for the computation of basic and diluted earnings (loss) per share*		$	(559	)		$	(2,446	)		$	417
Weighted average number of shares used in the computation of basic earnings (loss) per share			1,119				1,110				1,102
Weighted average number of shares used in the computation of diluted earnings (loss) per share			1,119				1,110				1,107

* Net income (loss) presented in the table above for the year ended December 31, 2022 has been revised as discussed in note 1b.

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration